The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Pawel Buszman
Showing 1-13 of 13 articles
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska JJ,
Wijns W,
de Winter RJ,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg PG,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska JJ,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter RJ,
Serruys P,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning A,
Escaned J,
Wykrzykowska JJ,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H,
Holmvang L,
Richardt G,
Eberli F,
Stella P,
Buszman P,
Neumann F,
Serruys P,
Windecker S,
Widimský P,
Belardi J,
Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms
Buszman P,
Milewski K,
Pająk J,
Jelonek M,
Orlik B,
Krauze A,
Gwiazdowska-Nowotka B,
Wojakowski W,
Tellez A,
Granada JF,
Buszman P
October 20, 2014 | 10.4244/EIJV10I6A125
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry
Meliga E,
De Benedictis M,
Chieffo A,
Latib A,
Park S,
Kim Y,
Onuma Y,
Capranzano P,
Jegere S,
Makkar R,
Palacios I,
Buszman P,
Bande M,
Chakravarty T,
Mehran R,
Naber C,
Scrocca I,
Margey R,
Leon M,
Moses J,
Fajadet J,
Lefèvre T,
Morice M,
Erglis A,
Tamburino C,
Alfieri O,
Conte M,
Serruys P,
Colombo A
November 29, 2013 | 10.4244/EIJV9I7A133
The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)
Wykrzykowska JJ,
Serruys P,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Van Es G-A,
Jüni P,
Windecker S
November 30, 2011 | 10.4244/EIJV7I7A125
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
Wykrzykowska JJ,
Garg S,
Onuma Y,
de Vries T,
Morel M,
Van Es G-A,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Corti R,
Eberli F,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Jüni P,
Windecker S,
Serruys P
September 30, 2011 | 10.4244/EIJV7I5A97
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S,
Wykrzykowska JJ,
Serruys P,
de Vries T,
Buszman P,
Trznadel S,
Linke A,
Lenk K,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
Tyczynski P,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
March 21, 2011
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S,
Sarno G,
Serruys P,
de Vries T,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
June 30, 2010
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy
Wykrzykowska JJ,
Räber L,
Ton de Vries T,
Bressers M,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
Regar E,
Jüni P,
Windecker S,
Serruys P
August 14, 2009
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction.
Buszman P,
Szkróbka I,
Tendera Z,
Gruszka A,
Bialkowska B,
Parma R,
Wojakowski W,
Król M,
Kiesz SR,
Bochenek A,
Tendera M
August 20, 2005
1
Latest news
AHEAD OF PRINT
Design of the TARGET-FIRST randomised study
FREE ARTICLE - Giuseppe Tarantini et al
March 31, 2023
AHEAD OF PRINT
Oesophageal and gastric injuries in tricuspid TEER
FREE ARTICLE - Tanja Kuecken et al
March 29, 2023
AHEAD OF PRINT
Heavily calcified CTOs: an expert review from the European CTO Club
FREE ARTICLE - Kambis Mashayekhi et al
March 27, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke